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Abstract
Background: On March 19, 2020, the governor of the State of California, Gavin
Newsom, issued executive stay at home order due to the coronavirus disease (COVID19) pandemic (State of California, 2020). In a private psychiatric practice in southern
California treating patients with anxiety and depression, psychotherapy treatment was
abruptly affected by that order. The purpose of this project was to transition from onsite
to online psychotherapy visits to ensure the continuity of care and facilitate patients’
progress in dealing with mental illnesses during the COVID-19 crisis.
Aims: The proposed solution to the problem of decreased access to care during the
pandemic was to continue psychotherapy in patients with anxiety or depression via
telepsychiatry, thus contributing to reduced symptomatology.
Methods: Eight patients participated in the project. Outcome data were collected to
assess symptoms changes and overall quality of life in patients who received
psychotherapy treatment for anxiety and/or depression via telepsychiatry. The results
across patients were assessed after the sixth and twelfth telepsychotherapy sessions.
Results: Mean patient health questionnaire scores (PHQ-9) decreased 58.5% at midterm
and 75.5% at final tests and mean general anxiety disorder questionnaire (GAD-7) scores
decreased 61.3% at midterm and 85.7% at final tests. Mean health related quality of life
questionnaire (HRQoL-14) scores for unhealthy days decreased 79.7% at final tests.
Conclusions: This project calls for the need for a practice change by promoting
telepsychiatry treatment as the gold standard of care for patients with mental illnesses
during epidemics and other traumatic events restricting access to care.
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Transitioning from Onsite to Online Psychotherapy Visits during the COVID-19 Crisis
Description of the Clinical Problem
Mental illness is a medical problem involving changes in emotions, thoughts, and
behaviors; which may influence an individual’s ability to function effectively and may
present in many forms with mild to severe symptoms (American Psychiatric Association
[APA], 2018b). In 2019, the National Alliance on Mental Illness (NAMI) reported that
millions of people in the United States were affected by mental illness each year and
estimated that one in five American adults experience mental illness, with one in 25
experiencing serious mental illness (NAMI, n.d.). According to the World Health
Organization (WHO), “Mental health conditions are increasing worldwide with a 13%
rise in the last decade and two of the most common mental health conditions, depression
and anxiety, cost the global economy $1 trillion each year.” (WHO, n.d.).
Unfortunately, those with mental illness face multiple challenges including those
posed by the coronavirus disease (COVID-19) pandemic. On March 4, 2020, the
governor of the State of California, Gavin Newsom, proclaimed a state of emergency to
exist in California as a result of COVID-19, and on March 19, 2020, he consequently
issued executive stay at home order N-33-20 to protect the public health and safety (State
of California, 2020). The stay-at-home order limited access to mental health care because
many services had to be stopped abruptly and many practices even had to close their
doors due to the restrictions generated by the order.
The COVID-19 pandemic resulted in stress and uncertainty for the entire
population. For those with mental illness, lack of access to care in this time of stress
increased their vulnerability and put them at higher risk for deteriorating mental health
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and other comorbidities, leading, in the worst-case scenario, to suicide. The Centers for
Disease Control and Prevention (CDC) announced that during a crisis like a pandemic,
feelings of isolation, depression, anxiety, and other emotional or financial stresses are
known to increase the risk for suicide, and recommended that people with preexisting
mental health conditions should continue with their treatment and be aware of new or
worsening symptoms (CDC, n.d.).
In a private psychiatric practice in southern California treating patients with
different types of mental illnesses including anxiety and depression, psychotherapy
treatment was abruptly affected by the stay-at-home order. Current evidence-based (EB)
treatments for people with mental illness include psychotherapy or counseling,
medication, or a combination of both. These are the treatment modalities that have been
effectively provided in the practice for the management and amelioration of patients’
mental health conditions. Therefore, transitioning from onsite to online psychotherapy
visits was an important strategy to ensure the continuity of care and facilitate patients’
progress in dealing with mental illnesses during the COVID-19 crisis.
Proposed Evidence-based Solutions
A literature review was conducted using the following nursing and health sciences
databases: CINAHL, Cochrane Central Register of Controlled Trials, PsycARTICLES,
PsycINFO, and PubMed. Keywords used for the initial search were telepsychiatry,
telemental health, telehealth, telemedicine, telepsychology, telepsychotherapy,
videoconferencing, psychotherapy, depression, anxiety, mental illness, and pandemic.
The initial search resulted in 14,634 articles. Those articles were then narrowed down to
full-text articles, published in English in the past 10 years, with a human population,
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resulting in 1,159 articles reviewed. A total of 7 articles were selected because they
demonstrated evidence-based solutions that resulted in increased access to care and
improved patient outcomes. The levels and types of evidence of the articles were rated
using John Hopkin’s Appendix D evidence level and quality guide (Dang & Dearholt,
2017). Six articles were rated as level I-A - randomized controlled trials, systematic
reviews or meta-analyses, and one was rated as level V-A - literature reviews or opinions
of nationally recognized experts based on scientific evidence.
The proposed solution to the problem of decreased access to care during the
pandemic was to continue psychotherapy in patients with anxiety or depression during
the COVID-19 crisis via telepsychiatry, thus contributing to reduced symptomatology. In
their study, Bashshur, Shannon, Bashshur, and Yellowlees (2016) conducted a literature
review on the effects of telemental health in the treatment of mental illnesses, in which
they analyzed 25 studies (23 randomized controlled trials [RTCs], one survey, and one
prospective cohort study). All of the studies focused on health outcomes including
symptoms and quality of life improvement. Generally, the studies indicated that
telemental health was an effective treatment for depression and anxiety disorders,
improved mental healthcare in primary care settings, and improved outcomes when
patients had comorbid medical conditions. In addition, the studies demonstrated that
telemental health provided a useful link for patients with special needs and made care
accessible in areas with limited or no professional mental health resources (Bashshur et
al., 2016).
Another study that included 65 reviews and meta-analyses evaluating the efficacy
of guided and unguided eHealth approaches to psychotherapy, concluded that either
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guided or unguided eHealth was acceptable to patients and effective in improving
depression, anxiety, alcohol-related problems, and general mental health compared to
being on a waitlist for care. In addition, the studies demonstrated that either guided or
unguided eHealth enhanced traditional psychotherapy treatment by being an adjunctive
component to it (Bennett, Ruggero, Sever, & Yanouri, 2020). Similarly, a systematic
review by Harerimana, Forchuk, and O’Regan (2019) analyzed nine studies that
examined the effects of telehealth provided to older adults with depressive symptoms.
They concluded that telehealth had a significant impact on health outcomes, including
reduced depressive symptoms, hospital admissions, and emergency visits, as well as
improved access to care and better cognitive functioning.
In another study, Choi et al. (2014) completed an RCT analyzing depression and
disability outcomes of telehealth problem-solving therapy (PST) provided via skype
video call compared to in-person PST and telephone care calls for 158 low-income
homebound older adults. They found both tele-PST and in-person PST were efficacious
treatments, however, the effects of tele-PST on both depression and disability outcomes
were sustained significantly longer than those of in-person PST over a six-month period
following therapy. Effect sizes for the Hamilton rating scale for depression (HAMD)
score changes at 36 weeks were 0.68 for tele-PST and 0.20 for in-person PST, and effect
sizes for the World Health Organization disability assessment schedule (WHODAS)
score changes at 36 weeks were 0.47 for tele-PST and 0.25 for in-person PST (Choi et al.,
2014).
In another RCT study, Morriss et al. (2019) investigated whether clinical and
economic outcomes were improved by providing remote cognitive behavioral therapy
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(RCBT) via videoconferencing or telephone to 156 repeat users of unscheduled care with
severe health anxiety compared to treatment as usual (TAU). RCBT significantly reduced
health anxiety scores at 6, 9, and 12 months compared to the TAU group (mean change
difference HAI = –2.81, 95% confidence interval [CI] = –5.11 to –0.50, P = 0.017). In
addition, the RCBT group showed significantly greater reductions in generalized anxiety
at 6 and 12 months and depression at 12 months, and improved overall health at 12
months (Morriss et al., 2019).
Finally, the Behavior Therapy Journal published two RCT studies in 2015 that
evaluated clinical and cost-effectiveness of therapist-guided internet-delivered cognitive
behavior therapy for older adults with symptoms of anxiety and depression. These studies
indicated that the treatment groups had significantly lower general anxiety disorder
questionnaire (GAD-7) and patient health questionnaire (PHQ-9) scores than the waitlist
control groups ( p < .001) at the end of treatment. In addition, the GAD-7 and PHQ-9
scores of the treatment groups post-treatment and at 3 and 12 months were all
significantly lower than their pretreatment scores ( p < .001) (Dear et al., 2015; Titov et
al., 2015).
Methods
EBP Model
The Iowa model of evidence-based practice (EBP) is a practice model that guides
clinicians in the use of evidence to improve health care outcomes (Rycroft-Malone &
Bucknall, 2010). This model has been validated as a practical tool for the EBP process
across diverse settings. It links practice changes within the system and promotes
excellence in health care (Buckwalter et al., 2017). The Iowa model has the major
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strengths of guiding the process of applying evidence in practice, addressing how to
select priority EBP topics, and facilitating project implementation and evaluation of
resulting changes in patient and/or staff outcomes. Decision points in the model assist in
driving the process forward (Bliss-Holtz, 2007). The Iowa model is appropriate for
various health care disciplines including physicians, nurses, physical therapists, and allied
health personnel (Rycroft-Malone & Bucknall, 2010).
The Iowa model was chosen because it provided valuable tools that guided
implementation of the project, beginning with identification of a clinical problem and
generation of a practice question that led to piloting a practice change and evaluation of
its effects on patient outcomes. The main goals of the project were to maintain access to
mental health care services and to decrease levels of anxiety and/or depression
experienced by clients by providing online EB psychotherapy treatment during the
COVID-19 crisis.
Project Approval
The project proposal was presented by the project leader to the lead psychiatrist of
a private psychiatric practice and the project leader’s faculty advisor via remote
technology to discuss the identification of the problem, background information, data
found in literature reviews, the purpose of the study, its importance, its design, and the
process for the implementation. Consequently, the project was approved by both of them,
whose letters of approval were then obtained. As a result, an application letter for
approval was then submitted to the University of San Diego (USD) Institutional Review
Board (IRB) entity. The application letter would have preferably been submitted in
person, but due to the COVID-19 restrictions, the letter was submitted via email. The
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project leader submitted the application letter for approval and received guidance from
USD faculty advisor. Once the project was approved by the IRB, the project was
implemented.
Stakeholder Identification
This EBP project consisted of two types of stakeholders; process stakeholders and
outcome stakeholders. The process stakeholders are the ones who would want updates of
the project and, thus, received updates on a weekly or monthly basis. The outcome
stakeholders are the ones who would be interested in the results of the project and, thus,
were informed of the results at the end of the project after its six-month timeframe. The
person responsible for communicating all updates and results of the project to all
stakeholders was the project leader.
Process stakeholders consisted of USD IRB entity, lead psychiatrist, and project
leader’s faculty advisor. The lead psychiatrist received weekly email updates regarding
the project and met with the project leader via monthly videoconference or telephone
meetings at which updates and recommendations were discussed. The project leader’s
faculty advisor received electronic weekly updates on the project and also met with the
project leader on a monthly or bi-monthly basis via videoconference. Outcome
stakeholders consisted of patients receiving telepsychotherapy, the USD IRB, practice
providers, and other mental health professionals. The final results were presented at a
stakeholders’ presentation at the practice and at the USD Doctor of Nursing Practice
(DNP) project presentation day.
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Description of EBP Project, Facilitators & Barriers
The objective of this EBP project was to transition the utilization of onsite
psychotherapy treatment into online psychotherapy to help maintain access to mental
health care services and to continue reducing the severity of symptoms for patients with a
diagnosis of anxiety and/or depression at a private psychiatric practice during the
COVID-19 Crisis. The project leader provided EB psychotherapy treatments, such as
cognitive behavioral therapy (CBT), supportive psychotherapy, and counseling, via
telepsychiatry. Telepsychiatry, also known as telemedicine, telehealth, telemental health,
and telepsychology, is a general term referring to the delivery of mental health care
services at a distance via videoconferencing or telephone. According to the APA (2018a),
telepsychiatry using video conferencing is a validated and effective practice of
psychiatric medicine that increases access to care. Therefore, for the purpose of this
project, telepsychiatry was provided via video using Zoom technology by means of
which the patient and the project leader were able to see each other for individual
psychotherapy using their own computers or cellphone devices.
The EBP project took place over 6 months from June to November of 2020.
Patients with a diagnosis of anxiety and/or depression and in need to start CBT treatment,
were initially informed by lead psychiatrist that psychotherapy treatment was going to
continue to be available to them via telepsychiatry in order to maintain continuity of care
and achievement of desired clinical outcome. During the timeframe of the project, lead
psychiatrist recommended eight patients to participate in the project, and thus, all eight
were selected. Therefore, patients’ severity of depression and/or anxiety was assessed
using the PHQ-9 questionnaire or the GAD-7 questionnaire, respectively, before the
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initial telepsychotherapy session, at midterm after their sixth session, and at the end after
their 12th session. In addition, patients’ quality of life was evaluated using the healthrelated quality of life questionnaire (HRQOL-14), before their initial telepsychotherapy
session and after the twelfth session. All data were gathered by the project leader who
compared them across the three time periods.
Facilitators for this project included the lead psychiatrist who is also the project
leader’s mentor, the support of the University of San Diego (USD) Hahn School of
Nursing and Health Science, and the project leader’s faculty advisor. Besides, increasing
the knowledge of patients and their families by educating them about the positive results
of EB psychotherapy treatments via telepsychiatry would add them also as key
facilitators for this project. Barriers include patients’ resistance to change, resistance due
to the stigma of mental illness, and patients’ noncompliance. To overcome these barriers,
studies resulting in improved patients’ outcomes by the use of EB psychotherapy
treatments were presented and explained to patients via Zoom technology. In addition,
weekly emails and video calls were provided to patients to encourage their participation
and compliance.
Process Indicator Data Monitoring
This EBP project consisted of different process indicators that were monitored
during the implementation of the project. Initially, educating about telepsychotherapy for
the treatment of anxiety and/or depression was provided to patients; before and during the
implementation of the project. This was achieved by providing educational handouts via
email and Zoom technology. One process indicator included the number of weekly
emails sent to patients to remind them of the tools and skills learned in the psychotherapy
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sessions and to motivate their participation. A second process indicator was the number
of weekly or biweekly telepsychotherapy sessions conducted. In addition, psychotherapy
sessions were monitored by the lead psychiatrist for quality of practice. Finally, patients’
follow-up appointments were monitored for no-shows or cancelations to ensure patients
got rescheduled and, thus, were able to continue receiving consistent treatments. These
data were monitored daily to facilitate rescheduling as needed.
Outcome Indicator Data Monitoring
This EBP project additionally consisted of outcome indicators that are known to
be used for monitoring the results of interventions used in a project. Project outcome
indicators included patients’ anxiety or depression scores; collected monthly using the
GAD-7 and PHQ-9 questionnaires, respectively. These questionnaires were collected via
email after they were completed by patients prior to their initial psychotherapy session
and after their sixth and twelfth session. Initial data were collected at the beginning of the
project and were compared to data collected after to assess symptom changes.
HRQoL-14 questionnaires were used as another outcome indicator to assess the
effect of telepsychotherapy on patients’ functionality and quality of life. These data were
also collected before receiving telepsychotherapy and after patients’ twelfth
psychotherapy sessions, when patients described their overall health when compared to
their health before participating in this project.
Data Analysis and Results
Data Analysis
Outcome data were collected to assess symptoms changes and overall quality of
life in patients who received psychotherapy treatment for anxiety and/or depression via
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telepsychiatry. The results were analyzed for each patient after the sixth and twelfth
telepsychotherapy sessions, and the final results across patients were assessed at the end
of the project’s six-month timeframe.
Project Participation
A total of eight patients participated in the project - seven Hispanic females and
one Hispanic male between the ages of 31 and 58. Four patients were being treated for
depression and all had a diagnosis of anxiety. Telepsychotherapy sessions were
conducted in Spanish and English, as per patients’ preferences, and all patients completed
the 12 psychotherapy sessions via telepsychiatry.
Project Outcomes
At the midterm and final telepsychotherapy, there were significant improvements
noted across all outcome measures. Mean PHQ-9 scores for the four patients with
depression demonstrated a 58.5% decrease from the initial tests (M = 13.25) to midterm
tests (M = 5.5), and a 75.5% decrease in mean scores from the initial tests to the final
tests (M = 3.25); indicating significant improvements from moderate and moderately
severe depression to mild and minimal depression across all subjects (Figure 1).
Across all patients, mean GAD-7 scores for anxiety demonstrated a 61.3%
decrease in mean scores from the initial tests (M = 14.87) to midterm tests (M = 5.75),
and an 85.7% decrease in mean scores from the initial tests to the final tests (M = 2.12)
also indicating significant improvements from moderate and severe anxiety to mild and
minimal anxiety across all subjects (Figure 2).
Furthermore, significant improvements in the number of reported unhealthy days
were seen across all subjects after evaluating and comparing the HRQoL scores from
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their initial and final questionaries (Figure 3). Across all patients, mean HRQoL scores
for unhealthy days demonstrated a 79.7% decrease from the initial tests (M = 19.75) to
the final tests (M = 4).
Figure 1
Patient Health Questionnaire (PHQ-9) Scores for Depression
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Figure 2
General Anxiety Disorder Questionnaire (GAD-7) Scores for Anxiety
Mean Score Reduced by 61.3% at Midterm & 85.7% at Final
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Figure 3
Health Related Quality of Life Questionnaire Scores for Unhealthy Days
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Cost/Benefit Analysis
There were no costs associated with this EBP project. The project leader, who
is a Doctor of nursing practice (DNP) psychiatric mental health nurse practitioner
(PMHNP) student, volunteered his time as a therapist to provide therapy sessions to all
patients included in this project. The cost to deliver therapy includes the cost of using the
Zoom application plus the therapist’s time. There was no cost for the use of the Zoom
application as this was a free application, and the cost for the therapist’s time would have
been $65 per hour. He provided a total of 77 hours of therapy; equating to a total cost of
$5,005 for the therapist’s time. However, since this was a volunteered time, the cost was
considered as savings instead. Copies of the CBT worksheets, PHQ-9, GAD-7, and
HRQoL-14 forms did not create any cost either as they all were sent and filled out
electronically.
In the United States in 2010, 15,446,771 people were estimated to have major
depressive disorder (MDD) and the financial hardship of this disorder was calculated to
be $210.5 billion (Greenberg, Fournier, Sisitsky, Pike, & Kessler, 2015). In addition,
WHO (2016) calculated that the number of people suffering from depression and/or
anxiety increased by almost 50% from $416 million to $615 million between 1990 and
2013, and also estimated that, during emergencies, such as the COVID-19 pandemic, as
many as 1 in 5 people are affected by depression and/or anxiety. Failure to provide
effective treatment of mental illnesses such as depression and anxiety is known to
increase the risk for other comorbidities, thus resulting in a more costly financial burden.
Therefore, implementing this EBP project not only reduced the costs caused by these
disorders but also resulted in attaining higher-quality, longer lives free of preventable
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disability, which is one of the goals of Healthy People 2020. Estimates of the costs and
benefits of the project are provided in Table 1.
Table 1
DNP Project – Cost-Benefit Analysis
Resources

Cost

Rationale

Cost to deliver therapy:
Cost of Zoom application
plus therapist’s time
($65/hour)
PHQ-9, GAD-7, and
HRQoL-14 Questionnaires,
and CBT worksheets: 128
copies
Benefits

Cost of Zoom: $0.00
Therapist time: $65.00 x
77 hours = ($5,005)

Considered instead as cost
savings since this was
volunteered time

$0.00

Forms sent and filled out
electronically

15,446,771 MDD cases x
$13,627.44 in treatment
cost per case
People suffering from
depression and/or anxiety
between the years 1990 and
2013
Invaluable benefits

$210.5 billion

Cost

Increased by almost 50%
from $416 million to $615
million

Rationale
This DNP project helped
reduce the yearly cost of
depression
This DNP project helped
reduce the yearly cost of
depression and anxiety

Improved severity of symptoms of depression and anxiety
Improved functionality and quality of life
Improved access to mental health care during the COVID19 pandemic

Implications for Research and Practice
Project Impact
Telepsychiatry treatment is fundamental for the continued management of mental
illnesses during the COVID-19 crisis. This project improved patient outcomes.
Continuity of care was maintained, while patients and families acquired increased
knowledge of the EB treatments available to them. In addition, patients exhibited
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improved symptoms, functionality, and quality of life as measured by the HRQoL, PHQ9, and GAD-7 screening tools.
Sustainability
As the main goal of this EBP project was to improve patient outcomes and access
to mental health care, the new practice change must remain sustained until it is possible
to return to in-person care. The first step to ensure the sustainability of this project is to
continue seeing patients via telepsychiatry during the COVID-19 restrictions and to
continue collecting HRQol-14, GAD-7, and PHQ-9 questionnaires monthly and compare
them every 6 months. This should be done to continue access to mental health care and to
continue monitoring symptom severity and quality of life. The second step to ensure
sustainability is to standardize access to mental health care during the COVID-19
restrictions and other similar events via telepsychiatry. This should be accomplished by
having an accessibly written guideline to telepsychiatry for all clinicians, with a list of all
the different types of psychiatric-mental health treatments that can be provided to patients
via telepsychiatry. Continued monitoring of outcome measures and standardizing the
treatment of mental illness via telepsychiatry during the similar catastrophic events can
improve mental health care and its effectiveness.
Conclusions
Abrupt discontinuation of access to mental health care services presents various
clinical problems in the management of mental illnesses, including worsening of
symptoms and poor long-term outcomes. The telepsychiatry intervention used in this
project demonstrated that mental illnesses can be managed efficiently and effectively via
distance mechanisms. It can also be concluded that providing psychotherapy via
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telepsychiatry has been successful not only in decreasing symptomatology, but also in
improving functionality and quality of life in patients with depression and/or anxiety.
This EBP project calls for the need for a practice change by promoting telepsychiatry
treatment as the gold standard of care for patients with mental illnesses during epidemics
and other traumatic events restricting access to care.
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